RxDoctor Payments Data

Donna Whitt, MD

Family Medicine · Siler City, NCNPI 1295955268

Payments from drug & device makers

$3,691in general payments, 2019–2025

Across 201 payments — averaging $18.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • Pfizer$452
  • Lilly USA, LLC$442
  • AbbVie$246
  • Johnson & Johnson$201
  • Alkermes, Inc.$169
  • plus $1K from 21 others

What the payments were for

  • Food & beverage$3,677100%
  • Education$150%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,691 in reported general payments places this provider in the 85th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$58,114
Medicare patients
124
Services billed
1,186

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide22$27,027
JardianceEmpagliflozin25$25,260
EliquisApixaban27$16,109
MyrbetriqMirabegron15$9,883
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$6,697
Repatha SureclickEvolocumab12$6,559
SymbicortBudesonide/Formoterol Fumarate15$4,854
Fluticasone-SalmeterolFluticasone Propion/Salmeterol17$3,391
ShingrixVaricella-Zoster Ge/As01b/Pf11$2,465
SynthroidLevothyroxine Sodium16$2,078
Valsartan35$1,689
Levothyroxine Sodium105$1,516
Albuterol Sulfate HfaAlbuterol Sulfate47$1,183
Duloxetine Hcl37$1,162
Irbesartan33$1,063

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$1,103$27,02722 claims
PfizerEliquis$452$16,10927 claims
GSKTrelegy Ellipta, Shingrix$105$9,16223 claims
AstraZenecaSymbicort$128$4,85415 claims
AbbVieSynthroid$246$2,07816 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Siler City

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →